Whelix is building the physical validation layer for AI-driven biology, starting with intelligent robotic systems that automate mammalian cell culture end-to-end. As AI accelerates discovery in the digital world, every new hypothesis, molecule, and therapy still needs to be validated in living cells. Cell culture remains one of the most manual, variable, and failure-prone workflows across drug discovery, cell therapy, and biomanufacturing. Our platforms combine purpose-built hardware, computer vision, digital twin simulation, and agentic software to automate incubation, liquid handling, imaging, protocol execution, and cell monitoring. By turning cell culture into reproducible, 24/7 lab infrastructure, Whelix helps scientists run more experiments, generate more consistent biology, and accelerate the path from in silico design to living-cell validation.
| Website | https://www.whelix.co |
| Employees | 8 (4 on RocketReach) |
| Industry | Robotics Engineering |
Looking for a particular Whelix employee's phone or email?
Xinyu Wang is the Cofounder, CTO of Whelix.
4 people are employed at Whelix.
Whelix is based in Boston, Massachusetts.